On ECHEMI
Home > Drugs > Jinling Pharmaceutical Co., Ltd. Nanjing Jinling Pharmaceutical Factory
Jinling Pharmaceutical Co., Ltd. Nanjing Jinling Pharmaceutical Factory
  • Founded in:

    1996-09-16
  • Country:

    China China
  • Address:

    No. 58, Xingang Avenue, Nanjing Economic and Technological Development Zone
  • Tax NO.:

    9132019270413930XB
  • Registered Funds:

    -
  • Email:

Related Drugs
Inosine injection
Chemical name: 9beta;-D-ribosyl hypoxanthine, molecular formula: C10H12N4O5
Name Description Content CAS NO. Registered Holders
9beta;-D-ribosyl hypoxanthine

This product can directly penetrate the cell membrane into the body cells, activate pyruvate oxidase, so that cells in a low-energy and hypoxic state can continue to metabolize smoothly, and participate in the energy metabolism and protein synthesis of the human body.

More

This product can directly penetrate the cell membrane into the body cells, activate pyruvate oxidase, so that cells in a low-energy and hypoxic state can continue to metabolize smoothly, and participate in the energy metabolism and protein synthesis of the human body.

0
Diclofenac Sodium Injection
The main ingredient of this product is: diclofenac sodium; the chemical name is: sodium o-(2,6-dichloroanilino)-phenylacetate.
Name Description Content CAS NO. Registered Holders
Diclofenac sodium

This product is a non-steroidal anti-inflammatory analgesic that has anti-inflammatory effects such as inhibiting prostaglandin synthase, inhibiting inflammatory exudation, and reducing redness and swelling. It can also inhibit the formation and release of RGE, histamine, 5-hydroxytryptamine, etc. in local inflamed tissues and reduce the inflammatory pain effects of inflammatory transmitters.

More

This product is a non-steroidal anti-inflammatory analgesic that has anti-inflammatory effects such as inhibiting prostaglandin synthase, inhibiting inflammatory exudation, and reducing redness and swelling. It can also inhibit the formation and release of RGE, histamine, 5-hydroxytryptamine, etc. in local inflamed tissues and reduce the inflammatory pain effects of inflammatory transmitters.

15307-79-6 55
Diclofenac Sodium Injection
The main ingredient of this product is: diclofenac sodium; the chemical name is: sodium o-(2,6-dichloroanilino)-phenylacetate.
Name Description Content CAS NO. Registered Holders
Diclofenac sodium

This product is a non-steroidal anti-inflammatory analgesic that has anti-inflammatory effects such as inhibiting prostaglandin synthase, inhibiting inflammatory exudation, and reducing redness and swelling. It can also inhibit the formation and release of RGE, histamine, 5-hydroxytryptamine, etc. in local inflamed tissues and reduce the inflammatory pain effects of inflammatory transmitters.

More

This product is a non-steroidal anti-inflammatory analgesic that has anti-inflammatory effects such as inhibiting prostaglandin synthase, inhibiting inflammatory exudation, and reducing redness and swelling. It can also inhibit the formation and release of RGE, histamine, 5-hydroxytryptamine, etc. in local inflamed tissues and reduce the inflammatory pain effects of inflammatory transmitters.

15307-79-6 55
Oleanolic acid capsules
Oleanolic acid
Name Description Content CAS NO. Registered Holders
Oleanolic acid

It has a certain protective effect on liver damage, can reduce elevated serum alanine aminotransferase, promote liver cell regeneration, and accelerate the repair of necrotic tissue.

More

It has a certain protective effect on liver damage, can reduce elevated serum alanine aminotransferase, promote liver cell regeneration, and accelerate the repair of necrotic tissue.

508-02-1 10
Apridin Hydrochloride Tablets
Aprindine hydrochloride. Chemical name: N, N'-diethyl-N'-2-indanyl-N'-phenyl-1,3-propylenediamine monohydrochloride.
Name Description Content CAS NO. Registered Holders
APRINDINE HCL

This product belongs to Class Ib antiarrhythmic drugs, inhibits the permeability of cell membrane to Na, but does not promote K outflow. It can slow down the conduction of various parts of the cardiac conduction system, reduce membrane reactivity, increase the excitation threshold, prolong the effective adaptation period of the atrium, atrioventricular node, His-Purkinje system (Purkinjes fibers) and ventricle, and block the forward and reverse conduction of the bypass pathway.

More

This product belongs to Class Ib antiarrhythmic drugs, inhibits the permeability of cell membrane to Na, but does not promote K outflow. It can slow down the conduction of various parts of the cardiac conduction system, reduce membrane reactivity, increase the excitation threshold, prolong the effective adaptation period of the atrium, atrioventricular node, His-Purkinje system (Purkinjes fibers) and ventricle, and block the forward and reverse conduction of the bypass pathway.

33237-74-0 2
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.